Document is current
Any future updates will be listed below
-
Authors
Takano, Yuko https://orcid.org/0000-0002-3753-7683
Mizuno, Kazuyuki
Iwase, Madoka
Morita, Sachi
Torii, Nao
Kikumori, Toyone
Ando, Yuichi
-
Funding
Funding for this research was provided by:
Nagoya University
- License Information
-
More Information
Article History
Received: 4 December 2024
Accepted: 18 April 2025
First Online: 2 May 2025
Declarations
:
: YT received a research grant from Eli Lilly and speaker honorarium from Chugai, MSD, Eli Lilly Japan K.K., Pfizer, Dai-ichi Sankyo, and AstraZeneca. MI received a research grant from AstraZeneca and Pfizer and speaker honorarium from Chugai., MSD, Eli Lilly, Pfizer, Kyowa Kirin, Taiho, and Exact Sciences. TK received a speaker honorarium from Chugai, Daiichi Sankyo, Pfizer, Novartis Pharma, Eli Lilly, Eisai, Kyowa Kirin, and Celltrion. YA received a research grant from Chugai, Kyowa Kirin, Nippon Kayaku, Mochida Pharma, Taiho, Daiichi Sankyo and BeiGene and speaker honorarium from Chugai, MSD K.K, Eli Lilly, Kyowa Kirin, Nippon Kayaku, Novartis Pharma, Daiichi Sankyo, Taiho, Ono, Guardant Health, and AstraZeneca. KM, SM, and NT have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individuals who agreed to be registered in the C-CAT database.
